| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LTD | Director | Ordinary Shares | 58,772 | $1,000,317 | $17.02 | 06 Jun 2025 | Direct |
| Adaptimmune Therapeutics PLC | Director | Option to purchase Ordinary Shares | 500,000 | 01 Jul 2022 | Direct | ||
| Moderna, Inc. | Chief Medical Officer | Stock Option (Right to Buy) | 121,120 | 30 Jun 2021 | Direct | ||
| TEVA PHARMACEUTICAL INDUSTRIES LTD | Director | Restricted Share Units | 14,492 | 05 Jun 2025 | Direct | ||
| Moderna, Inc. | Chief Medical Officer | Common Stock | 0 | $103.90 | 30 Jun 2021 | Direct | |
| TEVA PHARMACEUTICAL INDUSTRIES LTD | Director | Restricted Share Units | 0 | 15 Jun 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | 05 Jun 2025 | 3 | $0 | 4 | Director | 09 Jun 2025, 16:22 |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | 15 Jun 2024 | 2 | $0 | 4 | Director | 17 Jun 2024, 08:03 |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | 06 Jun 2024 | 1 | $0 | 4 | Director | 10 Jun 2024, 07:51 |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | 04 Aug 2023 | 2 | $0 | 4 | Director | 07 Aug 2023, 16:12 |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | 15 Jun 2023 | 1 | $0 | 4 | Director | 20 Jun 2023, 07:39 |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | 04 Nov 2022 | 2 | $0 | 4 | Director | 07 Nov 2022, 06:02 |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | 04 Aug 2022 | 1 | $0 | 4 | Director | 08 Aug 2022, 07:29 |
| ADAP | Adaptimmune Therapeutics PLC | 01 Jul 2022 | 1 | $0 | 4 | Director | 01 Jul 2022, 17:03 |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | 31 Dec 2021 | 1 | +$151 | 5 | Director | 10 Feb 2022, 15:15 |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | 04 Nov 2021 | 1 | $0 | 4 | Director | 08 Nov 2021, 15:02 |
| TEVA | TEVA PHARMACEUTICAL INDUSTRIES LTD | 01 Oct 2021 | 0 | $0 | 3 | Director | 04 Oct 2021, 07:21 |
| ADAP | Adaptimmune Therapeutics PLC | 01 Jul 2021 | 1 | $0 | 4 | Director | 02 Jul 2021, 17:03 |
| MRNA | Moderna, Inc. | 30 Jun 2021 | 3 | -$1,055,350 | 4 | Chief Medical Officer | 02 Jul 2021, 16:30 |
| MRNA | Moderna, Inc. | 23 Jun 2021 | 3 | -$968,600 | 4 | Chief Medical Officer | 25 Jun 2021, 17:22 |
| MRNA | Moderna, Inc. | 16 Jun 2021 | 3 | -$870,350 | 4 | Chief Medical Officer | 21 Jun 2021, 19:03 |
| MRNA | Moderna, Inc. | 09 Jun 2021 | 3 | -$931,850 | 4 | Chief Medical Officer | 11 Jun 2021, 16:14 |
| MRNA | Moderna, Inc. | 02 Jun 2021 | 3 | -$789,850 | 4 | Chief Medical Officer | 03 Jun 2021, 16:47 |
| MRNA | Moderna, Inc. | 26 May 2021 | 3 | -$713,850 | 4 | Chief Medical Officer | 27 May 2021, 16:11 |
| MRNA | Moderna, Inc. | 19 May 2021 | 3 | -$649,050 | 4 | Chief Medical Officer | 20 May 2021, 17:14 |
| MRNA | Moderna, Inc. | 12 May 2021 | 3 | -$640,900 | 4 | Chief Medical Officer | 13 May 2021, 16:03 |
| MRNA | Moderna, Inc. | 10 May 2021 | 8 | -$536,806 | 4 | Chief Medical Officer | 11 May 2021, 16:12 |